My Tiny Feed

independent.co.uk

Novo Nordisk: Deaths Linked to Compounded Copies of Wegovy and Ozempic

Novo Nordisk reports deaths and hospitalizations linked to compounded copies of its drugs, prompting a request for FDA ban.

Read original article in English

English

United Kingdom

HealthLifestyleHealthcareRegulationSupply ChainPharmaceuticalsDrug Safety

Novo NordiskFdaEli Lilly

Lars Fruergaard JorgensenKarsten Munk Knudsen

How are the copycat versions of Wegovy and Ozempic being distributed?: The copycat versions of Wegovy and Ozempic are being sold through online channels and health spas, bypassing the formal supply chain where Novo Nordisk and Eli Lilly sell their approved medicines.
What action has Novo Nordisk taken in response to the safety concerns?: Novo Nordisk has requested a ban from the FDA on compounding pharmacies producing copycat versions of Wegovy and Ozempic, citing safety concerns due to the complexity of the drugs' production.
What is the current status of Wegovy and Ozempic on the FDA shortage list?: Despite the drugs being listed as available on the FDA website, Wegovy and Ozempic remain on the agency's shortage list; Novo Nordisk is working to increase production capacity and resolve this issue.
What prompted Novo Nordisk's statement regarding the deaths and hospitalizations?: Novo Nordisk, a healthcare giant, reported awareness of 10 deaths and 100 hospitalizations linked to compounded copies of its weight-loss and diabetes drugs, Wegovy and Ozempic.
What is the legal basis for compounding pharmacies to create copies of brand-name medications in the US?: U.S. regulations permit compounding pharmacies to replicate brand-name drugs in short supply; however, Novo Nordisk argues that the complexity of Wegovy and Ozempic makes safe compounding by these pharmacies difficult.

Jan 22, 04:12

Combined Healthy Waist and Exercise Key to Minimizing Cancer Risk

A study of 315,000 Britons reveals that maintaining a healthy waist circumference (below 88cm for women and 102cm for men) and engaging in 150-300 minutes of moderate or 75-150 minutes of vigorous weekly exercise is crucial for minimizing cancer risk; meeting only one guideline is insufficient.

Jan 22, 16:07

10 Foods to Reduce Colon Cancer Risk Amidst Rising Cases

A nutritionist urges increased consumption of 10 fiber-rich foods—oats, peas, prunes, raspberries, black beans, popcorn, almonds, chia seeds, avocado, and sweet potatoes—to combat a 52% rise in UK colon cancer cases among under-50s over 30 years, potentially due to low fiber diets.

Jan 21, 10:09

High Blood Pressure and Diabetes Prevalence and Prevention in the US

Approximately half of US adults have high blood pressure, and over 10% have diabetes, significantly increasing heart disease and stroke risks; early diagnosis and treatment, even without symptoms, are crucial, with lifestyle changes and medications offering effective management.

Jan 21, 10:09

Sedentary Behavior: Health Risks and Mitigation Strategies

Prolonged sitting reduces blood vessel elasticity and brain blood flow; regular movement breaks, active commuting, and strength training are crucial for mitigating health risks.